Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

Roche

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.

Roche

FDA delays review of Novartis’ MS drug ofatumumab

FDA delays review of Novartis’ MS drug ofatumumab

If approved, ofatumumab (OMB157) will be a direct rival to Roche’s fast-growing MS therapy Ocrevus (ocrelizumab), which has exploded since its launch in 2017 and had revenues of

ASCO: Merck’s Keytruda tops chemo in MSI-H colorectal cancer

ASCO: Merck’s Keytruda tops chemo in MSI-H colorectal cancer Investigators could choose the chemotherapy-based regimen they used as the comparator in the trial, and a number opted for the combination of Roche’s Avastin (bevacizumab) with mFOLFOX6, which is

ASCO: Bavencio boosts survival post-chemo in bladder cancer

ASCO: Bavencio boosts survival post-chemo in bladder cancer AstraZeneca’s Imfinzi (durvalumab) and Roche’s Tecentriq (atezolizumab) which have transformed the prospects for bladder cancer patients.

Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir

Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir Roche and Gilead Sciences are joining forcers to fight COVID-19 with a 450-patient trial that will combine two drugs already being tested against coronavirus as monotherapies. ... The study – called REMDACTA – will start enrolling hospitalised

Finalists 2020

by Weber Shandwick. for Roche. Peter Impey. 90TEN. Rebecca Tait. 90TEN.  .

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics